There’s not a lot known about the new COVID-19 variant Omicron, but what scientists see…
dcorriganDecember 3, 2021
Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve…
dcorriganDecember 2, 2021
Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of…
dcorriganDecember 2, 2021
Another Greek letter has entered the vernacular. In late November, the World Health Organization designated SARS-CoV-2…
dcorriganDecember 1, 2021
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated…
dcorriganDecember 1, 2021
In honor of American Diabetes Month, the UW Department of Medicine's November faculty spotlight is…
dcorriganNovember 30, 2021
In January 2020, computational biologist Trevor Bedford told STAT’s Helen Branswell about the then-new coronavirus: “If it’s…
dcorriganNovember 29, 2021
A young child’s cerebellum is only one-fourth of its adult size, yet it contains the…
dcorriganNovember 25, 2021
Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing…
dcorriganNovember 24, 2021
